| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jade Biosciences, Inc. (JBIO) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. JBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.90M | $31.92M | - | |
| CFO | 526.0K | $8.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 | Niven Ralph74 | Chief Scientific Officer | Sale+OE | 2,250 | $16.26 | $36,576.00 | -58.3% | -4.6% | +2.6% | |
| May 19, 2023 | Gillies Hunter82 | Chief Medical Officer | Sale+OE | 65 | $19.50 | $1,267.50 | -2.0% | -19.7% | +10.9% | |
| May 17, 2023 | Gillies Hunter82 | Chief Medical Officer | Sale+OE | 1,090 | $19.59 | $21,355.83 | -25.1% | -24.0% | +12.6% | |
| May 8, 2023 | Dake Benjamin T77 | See Remarks | Sale+OE | 10,284 | $21.80 | $224,159.85 | -71.1% | -30.4% | -6.9% | |
| May 5, 2023 | Niven Ralph74 | Chief Scientific Officer | Sale+OE | 2,250 | $20.87 | $46,956.82 | -39.7% | -25.1% | -7.8% | |
| May 3, 2023 | Verwijs Marinus82 | Senior Vice President, Cmc | Sell | 759 | $20.79 | $15,779.38 | -100% | -22.9% | -4.6% | |
| May 2, 2023 | Noyes Timothy P81 | Chief Executive Officer | Sale+OE | 15,693 | $20.63 | $323,745.45 | -95.8% | -15.9% | +0.4% | |
| Apr 21, 2023 | Gillies Hunter82 | Chief Medical Officer | Sale+OE | 4,000 | $19.50 | $78,000.00 | -67.1% | -16.6% | +13.0% | |
| Apr 6, 2023 | Dake Benjamin T77 | See Remarks | Sale+OE | 10,283 | $18.17 | $186,828.74 | -100% | -6.9% | +37.0% | |
| Apr 5, 2023 | Niven Ralph74 | Chief Scientific Officer | Sale+OE | 2,250 | $18.20 | $40,942.29 | -37.5% | -8.2% | +56.9% |